80 results on '"Wallwiener D"'
Search Results
2. Unexpected malignant uterine pathology: Incidence, characteristics and outcome in a large single-center series of hysterectomies for presumed benign uterine disease
3. Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study
4. Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients
5. Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial
6. Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression
7. COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy
8. Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
9. Influence of zoledronic acid on disseminated tumor cells in primary breast cancer patients
10. Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer – Results of the eLEcTRA trial
11. Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: Recommendations for prevention and treatment
12. Bisphosphonate-induced osteonecrosis of the jaw (ONJ): Incidence and risk factors in patients with breast cancer and gynecological malignancies
13. Pathological Prenatal Doppler Sonography Findings and Their Association with Neonatal Cranial Ultrasound Abnormalities in a High Risk Collective
14. Salvage chemotherapy for metastatic breast cancer: results of a phase II study with bendamustine
15. Breast cancer patients' expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients
16. Is human chorionic gonadotropin directly involved in the regulation of human implantation?
17. Detection of disseminated tumor cells in patients with gynecological cancers
18. Different effects of estradiol and various antiestrogens on TNF-α-induced changes of biochemical markers for growth and invasion of human breast cancer cells
19. Skin-sparing mastectomy and immediate breast reconstruction: incidence of recurrence in patients with invasive breast cancer
20. Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study
21. Cardiac safety of trastuzumab in combination with epirubicin and cyclophosphamide in women with metastatic breast cancer: results of a phase I trial
22. Does 3-D sonography bring any advantage to noninvasive breast diagnostics?
23. Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group
24. Effect of tamoxifen and 2-methoxyestradiol alone and in combination on human breast cancer cell proliferation
25. Local and systemic tolerability of magnesium sulphate for tocolysis
26. Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia
27. A multicenter survey of complications associated with 21 676 operative hysteroscopies
28. 00030: INFORMATION NEEDS AND PREFERENCES OF WOMEN WITH ADJUVANT AND METASTATIC BREAST CANCER (BC): RESULTS OF A SURVEY IN GERMANY
29. Corrections to “Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression”
30. 1540P - Implementation of an interdisciplinary molecular tumor board in managing of advanced stage breast cancer
31. A newly developed morcellator creates a new dimension in minimally invasive surgery
32. Laparoscopic enterolysis before adjuvant radiotherapy in a case of endometrial cancer
33. 262 MMP11 Expression Increases During Progression of Breast Cancer
34. Complications in Laparoscopic Gynecologic Oncology
35. Laparoscopically Assisted Neovagina Using a New Surgical Procedure and New Developed Instruments in 152 Patients with Vaginal Aplasia
36. Stage I carcinoma of the Bartholin's gland managed with the detection of inguinal and pelvic sentinel lymph node
37. Comparison between circulating and disseminated tumor cells in breast cancer
38. Detection of disseminated tumor cells in bone marrow in patients with ductal carcinoma in situ
39. Expression of estrogen receptor (ER) in disseminated tumor cells of breast cancer patients
40. Expression and functional analysis of PGRMC1 in breast cancer
41. Evaluation of a RT-PCR based routine screening tool for the detection of disseminated epithelial cells in the bone marrow of breast cancer patients
42. 366: Experimental Models to Induce Standardized Adhesions in the Rat
43. 235: Adhesion Prophylaxis After Laparoscopic Myomectomy using a Novel Resorbable Membrane Consisting of D,L-Polylactid (Supraseal)
44. 236: Adhesion Prophylaxis Using a Novel Resorbable Biomembrane Consisting of D,L-Polylactid (Supraseal) - Experimental Results in the Rat Model
45. Efficacy of zoledronic acid for the reduction of bone marrow tumor cells in breast cancer patients receiving adjuvant therapy
46. P-384: Different expression of IGF-1, IGF-2 und IGF-1R in human endometrial stromal cells during decidualization in vitro and under the influence of hCG
47. Lactocapromer in membrane (XA-1-M)- and foil application (XA-1-F) serving as “artificial peritoneum” for adhesion prevention versus established “adhesion barriers” Interceed© (ORC), Adept© (IDT) and lactated ringer's solution (lRS) in an experimental animal study
48. Development of an in vitro model to evaluate innovative electrosurgical high-frequency coagulation techniques
49. Lactocapromer in membrane (XA-1-M) and foil application (XA-1-F) serving as “artificial peritoneum” for adhesion prevention versus established “adhesion barriers” interceed, adept, and ringer's lactate solution in an experimental animal study
50. Murine model of monocytic peritonitis: are glycodelin or thiazolidinedione new options in the treatment of endometriosis?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.